Nexien BioPharma, Inc.
NXEN · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $1,165 | $2,228 | $3,616 | $4,975 |
| - Cash | $4 | $35 | $117 | $18 |
| + Debt | $312 | $271 | $222 | $13 |
| Enterprise Value | $1,473 | $2,465 | $3,721 | $4,970 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$454 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$239 | -$362 | -$626 | -$1,860 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.004 | -0.006 | -0.011 | -0.034 |
| % Growth | 37.9% | 46.3% | 67.9% | – |
| Operating Cash Flow | -$64 | -$82 | -$75 | -$91 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$64 | -$82 | -$75 | -$91 |